DOP2013000063A - Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación - Google Patents

Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación

Info

Publication number
DOP2013000063A
DOP2013000063A DO2013000063A DO2013000063A DOP2013000063A DO P2013000063 A DOP2013000063 A DO P2013000063A DO 2013000063 A DO2013000063 A DO 2013000063A DO 2013000063 A DO2013000063 A DO 2013000063A DO P2013000063 A DOP2013000063 A DO P2013000063A
Authority
DO
Dominican Republic
Prior art keywords
preparation
pan
formula
intermediaries
cdk inhibitors
Prior art date
Application number
DO2013000063A
Other languages
English (en)
Inventor
Joachim Kruger
Jorg Gries
Kai Lovis
Jorma Hasssfeld
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44677881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2013000063(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of DOP2013000063A publication Critical patent/DOP2013000063A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/10—Compounds containing sulfur atoms doubly-bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Nuevo proceso para la preparación de inhibidores de pan-CDK de la fórmula (I), e intermediarios que se utilizan en la preparación.
DO2013000063A 2010-09-23 2013-03-22 Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación DOP2013000063A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102010046720A DE102010046720A1 (de) 2010-09-23 2010-09-23 Verfahren zur Herstellung von pan-CDK-Inhibitoren der Formel (l), sowie Intermediate der Herstellung

Publications (1)

Publication Number Publication Date
DOP2013000063A true DOP2013000063A (es) 2013-04-30

Family

ID=44677881

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000063A DOP2013000063A (es) 2010-09-23 2013-03-22 Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación

Country Status (32)

Country Link
US (1) US9359306B2 (es)
EP (1) EP2619186A1 (es)
JP (1) JP5969993B2 (es)
KR (1) KR20130109145A (es)
CN (1) CN103119026B (es)
AP (1) AP2013006816A0 (es)
AR (1) AR083171A1 (es)
AU (1) AU2011304365B2 (es)
BR (1) BR112013006720A2 (es)
CA (1) CA2811807A1 (es)
CL (1) CL2013000797A1 (es)
CO (1) CO6690779A2 (es)
CR (1) CR20130138A (es)
CU (2) CU20130044A7 (es)
DE (1) DE102010046720A1 (es)
DO (1) DOP2013000063A (es)
EC (1) ECSP13012520A (es)
GT (1) GT201300078A (es)
HK (1) HK1185615A1 (es)
IL (1) IL225352A0 (es)
MX (1) MX2013003338A (es)
MY (1) MY160625A (es)
NZ (1) NZ608448A (es)
PE (1) PE20140182A1 (es)
RU (1) RU2585621C2 (es)
SA (1) SA111320775B1 (es)
SG (1) SG188967A1 (es)
TW (1) TWI530488B (es)
UA (1) UA110626C2 (es)
UY (1) UY33624A (es)
WO (1) WO2012038411A1 (es)
ZA (1) ZA201301799B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201418243A (zh) 2012-11-15 2014-05-16 Bayer Pharma AG 含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
WO2014173815A1 (en) * 2013-04-23 2014-10-30 Bayer Pharma Aktiengesellschaft Use of (rs)-s-cyclopropyl-s-(4-{[4-{[(1r, 2r)-2-hydroxy-1-methylpropyl]oxy}-5- (trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulphoximide for the treatment of specific tumours
AR113344A1 (es) 2017-10-05 2020-04-22 Innovative Molecules Gmbh Enantiómeros de una serie de compuestos antivirales
AU2019221019B2 (en) 2018-02-13 2024-05-02 Bayer Ag Use of 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA964426B (en) * 1995-06-05 1997-03-06 Rhone Poulenc Agrochimie Pesticidal sulfur compounds
EP1291336A3 (en) 2001-09-05 2003-10-08 Solvias AG Preparation of optically active alpha-hydroxyethers
DE10349423A1 (de) * 2003-10-16 2005-06-16 Schering Ag Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
DE102005062742A1 (de) * 2005-12-22 2007-06-28 Bayer Schering Pharma Ag Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel
EP2022785A1 (en) * 2007-06-20 2009-02-11 Bayer Schering Pharma Aktiengesellschaft Alkynylpyrimidines as Tie2 kinase inhibitors
EP2179991A1 (de) 2008-10-21 2010-04-28 Bayer Schering Pharma Aktiengesellschaft Sulfoximinsubstituierte Anilino-Pyrimidinderivate als CDK-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
ECSP13012520A (es) 2013-05-31
ZA201301799B (en) 2014-05-28
DE102010046720A1 (de) 2012-03-29
AR083171A1 (es) 2013-02-06
UA110626C2 (uk) 2016-01-25
CO6690779A2 (es) 2013-06-17
SA111320775B1 (ar) 2015-02-03
SG188967A1 (en) 2013-05-31
IL225352A0 (en) 2013-06-27
CN103119026A (zh) 2013-05-22
TW201215596A (en) 2012-04-16
GT201300078A (es) 2014-11-26
CR20130138A (es) 2013-05-15
CU20130044A7 (es) 2013-07-31
MY160625A (en) 2017-03-15
WO2012038411A1 (de) 2012-03-29
RU2013118432A (ru) 2014-10-27
KR20130109145A (ko) 2013-10-07
RU2585621C2 (ru) 2016-05-27
TWI530488B (zh) 2016-04-21
EP2619186A1 (de) 2013-07-31
JP5969993B2 (ja) 2016-08-17
BR112013006720A2 (pt) 2016-06-14
US9359306B2 (en) 2016-06-07
AU2011304365B2 (en) 2015-02-05
AU2011304365A1 (en) 2013-04-11
MX2013003338A (es) 2013-06-24
NZ608448A (en) 2014-10-31
HK1185615A1 (en) 2014-02-21
US20130245261A1 (en) 2013-09-19
PE20140182A1 (es) 2014-02-14
AP2013006816A0 (en) 2013-04-30
JP2013542189A (ja) 2013-11-21
CN103119026B (zh) 2015-08-19
CA2811807A1 (en) 2012-03-29
CL2013000797A1 (es) 2013-09-13
CU20150165A7 (es) 2016-05-30
UY33624A (es) 2012-04-30

Similar Documents

Publication Publication Date Title
SV2010003718A (es) Inhibidores de bace
CL2017002283A1 (es) Formulaciones de anticuerpos y métodos (divisional de solicitud n°1081-2014)
TN2011000673A1 (en) Bace inhibitors
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
ECSP13012394A (es) Nuevas formas de dosificación de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa
CR20140529A (es) Anticuerpos e inmunoconjugados contra ly6e y métodos de uso
UY33958A (es) Inhibidores de la glucosilceramida sintasa
BR112013004490A2 (pt) aparelho para medir propriedade termodinâmicas de fluidos de reservatório, e método para medir propriedades termodinâmicas de fluidos de reservatório
CL2012003385A1 (es) Tratamiento para la incontinencia.
MX2019014654A (es) Agonistas de fgfr1 y sus metodos de uso.
ECSP088961A (es) Nuevos herbicidas
CR20140212A (es) Anticuerpos anti-htra1 y métodos de uso
UY33930A (es) Inhibidores novedosos de quinasas
UY33917A (es) ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?.
UY34527A (es) ?composiciones, métodos y kits para la preparación de proteínas recombinantes sialiladas?.
DOP2014000098A (es) 2-tiopirimidinonas
EA201301130A1 (ru) Имидазопиридазины в качестве ингибиторов акт киназы
MX353578B (es) Dihidrodiazpinocarbazolonas tetra o penta-ciclicas fusionadas como inhibidores de poli (adp-ribosa) polimerasa (parp).
DOP2012000260A (es) Uso de nuevos inhibidores de pan–cdk para tratar tumores
ECSP13012520A (es) Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación
UY34016A (es) Nuevo uso de aclidinio
BR112015015798A2 (pt) método para a preparação de um composto
UY34277A (es) Metodo para la eliminación del naftaleno
CU24289B1 (es) Nuevo procedimiento para la síntesis de la agomelatina
UY34626A (es) Proceso para la preparación estereoselectiva de pirazol carboxamida y compuestos intermediarios